Idioma English Español
Patient Support | Puentes Program Medical Staff | Medical Science Liaison Customers Suppliers

NILGABAN®

Active ingredient
Fulvestrant

Therapeutic action

Endocrine therapy.

How supplied

Dose and administration:The recommended dose is Nilgaban500 mg, intramuscularly, once a month, with an additional dose of 500 mg administered 2 weeks after the initial one.
Storage:Storage at  2°C – 8°C in the original carton, protected from light.

Available in

Bandera arArgentina (Nilgaban)

Bandera boBolivia (Nilgaban)

Bandera crCosta Rica (Nilgaban)

Bandera elEl Salvador (Nilgaban)

Bandera hnHonduras (Nilgaban)

Bandera pyParaguay (Nilgaban)

Bandera doRepública Dominicana (Nilgaban)

Download

Prospecto
ONCOLOGY
Envase de NILGABAN® Fulvestrant, medicamento para tratamiento de ONCOLOGY

Pharmaceutical Products

You can search by combining different criteria